Mikiko NAKAMURA

Person

Kashiwa-shi, JP

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-human CD69 antibody, and use thereof for medical purposes
- Patent number 10,865,247
- Issue date Dec 15, 2020
- GeneFrontier Corporation
- Kanehisa Kojoh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GPC3-targeting drug which is administered to patient responsive to...
- Patent number 10,782,300
- Issue date Sep 22, 2020
- Chugai Seiyaku Kabushiki Kaisha
- Toshihiko Ohtomo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibody against aggrecanase-type ADAMTS species for therapeu...
- Patent number 10,640,573
- Issue date May 5, 2020
- GeneFrontier Corporation
- Akira Miyakoshi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Composition for synthesizing protein with reduced lipopolysaccharid...
- Patent number 9,617,533
- Issue date Apr 11, 2017
- GeneFrontier Corporation
- Takashi Kanamori
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNF8-FHA domain-modified protein and method of producing the same
- Patent number 9,493,523
- Issue date Nov 15, 2016
- GeneFrontier Corporation
- Kanehisa Kojoh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Composition for synthesizing protein with reduced lipopolysaccharid...
- Patent number 9,175,327
- Issue date Nov 3, 2015
- GeneFrontier Corporation
- Takashi Kanamori
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
DRUG COMPOSITION FOR TREATING PEDIATRIC CANCERS
- Publication number 20240115578
- Publication date Apr 11, 2024
- Chugai SeiYaku Kabushiki Kaisha
- Jotaro SATO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIC PEPTIDE HAVING CTLA-4 INHIBITORY ACTIVITY AND USE THEREOF
- Publication number 20240092836
- Publication date Mar 21, 2024
- GENEFRONTIER CORPORATION
- Kanehisa KOJOH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-T CELL ANTIGEN-BINDING MOLECULE TO BE USED IN COMBINATION WITH...
- Publication number 20220348658
- Publication date Nov 3, 2022
- Chugai SeiYaku Kabushiki Kaisha
- Takahiro ISHIGURO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE REGIMEN FOR COMBINATION THERAPY USING PD-1 AXIS BINDING ANTA...
- Publication number 20200216542
- Publication date Jul 9, 2020
- Toshihiko OHTOMO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-HUMAN CD69 ANTIBODY, AND USE THEREOF FOR MEDICAL PURPOSES
- Publication number 20200199235
- Publication date Jun 25, 2020
- GENEFRONTIER CORPORATION
- Kanehisa Kojoh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODY AGAINST AGGRECANASE-TYPE ADAMTS SPECIES FOR THERAPEU...
- Publication number 20190233541
- Publication date Aug 1, 2019
- GeneFrontier Corporation
- Akira MIYAKOSHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-HUMAN CD69 ANTIBODY, AND USE THEREOF FOR MEDICAL PURPOSES
- Publication number 20190233521
- Publication date Aug 1, 2019
- GeneFrontier Corporation
- Kanehisa KOJOH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODY AGAINST AGGRECANASE-TYPE ADAMTS SPECIES FOR THERAPEU...
- Publication number 20160304622
- Publication date Oct 20, 2016
- GENEFRONTIER CORPORATION
- Akira MIYAKOSHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITION FOR SYNTHESIZING PROTEIN WITH REDUCED LIPOPOLYSACCHARID...
- Publication number 20160010079
- Publication date Jan 14, 2016
- GENEFRONTIER CORPORATION
- Takashi KANAMORI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GPC3-TARGETING DRUG WHICH IS ADMINISTERED TO PATIENT RESPONSIVE TO...
- Publication number 20150285806
- Publication date Oct 8, 2015
- Chugai Seiyaku Kabushiki Kaisha
- Toshihiko Ohtomo
- G01 - MEASURING TESTING
Information Patent Application
ANTI-HUMAN CD69 ANTIBODY, AND USE THEREOF FOR MEDICAL PURPOSES
- Publication number 20150118237
- Publication date Apr 30, 2015
- GENEFRONTIER CORPORATION
- Kanehisa Kojoh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RNF8-FHA DOMAIN-MODIFIED PROTEIN AND METHOD OF PRODUCING THE SAME
- Publication number 20130143299
- Publication date Jun 6, 2013
- GENEFRONTIER CORPORATION
- Kanehisa Kojoh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITION FOR SYNTHESIZING PROTEIN WITH REDUCED LIPOPOLYSACCHARID...
- Publication number 20120231496
- Publication date Sep 13, 2012
- THE UNIVERSITY OF TOKYO
- Takashi KANAMORI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Mikiko NAKAMURA

Person

Patents Grantslast 30 patents

Anti-human CD69 antibody, and use thereof for medical purposes

GPC3-targeting drug which is administered to patient responsive to...

Human antibody against aggrecanase-type ADAMTS species for therapeu...

Composition for synthesizing protein with reduced lipopolysaccharid...

RNF8-FHA domain-modified protein and method of producing the same

Composition for synthesizing protein with reduced lipopolysaccharid...

Patents Applicationslast 30 patents

DRUG COMPOSITION FOR TREATING PEDIATRIC CANCERS

CYCLIC PEPTIDE HAVING CTLA-4 INHIBITORY ACTIVITY AND USE THEREOF

ANTI-T CELL ANTIGEN-BINDING MOLECULE TO BE USED IN COMBINATION WITH...

DOSAGE REGIMEN FOR COMBINATION THERAPY USING PD-1 AXIS BINDING ANTA...

ANTI-HUMAN CD69 ANTIBODY, AND USE THEREOF FOR MEDICAL PURPOSES

HUMAN ANTIBODY AGAINST AGGRECANASE-TYPE ADAMTS SPECIES FOR THERAPEU...

ANTI-HUMAN CD69 ANTIBODY, AND USE THEREOF FOR MEDICAL PURPOSES

HUMAN ANTIBODY AGAINST AGGRECANASE-TYPE ADAMTS SPECIES FOR THERAPEU...

COMPOSITION FOR SYNTHESIZING PROTEIN WITH REDUCED LIPOPOLYSACCHARID...

GPC3-TARGETING DRUG WHICH IS ADMINISTERED TO PATIENT RESPONSIVE TO...

ANTI-HUMAN CD69 ANTIBODY, AND USE THEREOF FOR MEDICAL PURPOSES

RNF8-FHA DOMAIN-MODIFIED PROTEIN AND METHOD OF PRODUCING THE SAME

COMPOSITION FOR SYNTHESIZING PROTEIN WITH REDUCED LIPOPOLYSACCHARID...